The Memorial Sloan Kettering Cancer Center recently announced that it will spend $140 million in private funds to build an outpatient treatment and research facility.
The Memorial Sloan Kettering Cancer Center is the world’s oldest and largest private cancer research center and it is widely recognized for its contributions to cancer treatment and research. This new facility will be able to make huge strides in the development of cancer research.
Memorial Sloan Kettering is led by a group of highly experienced professionals, including Craig B. Thompson, Sloan Kettering President and CEO, William Ford of General Atlantic who is a member of its board of trustees, and Mortimer Zuckerman, who sits on the cancer center’s board of directors.
“This project fits with our vision to build up the health care industry in Nassau County and complements the educational institutions in the area,” County Executive Edward Mangano said in an interview.
Patients will be able to receive chemotherapy, radiation, and other treatments once the two-story, 105,000-square-foot facility is completed. The new center will also be the home to clinical research. According to Avice Meehan, a Memorial Sloan Kettering spokeswoman, the prestigious cancer center will absorb its Rockville Centre into the new facility.
This announcement is another example of the impressive power of philanthropy, as this project was made possible by using exclusively private funds.
Memorial Sloan Kettering Cancer Center is no stranger to the force philanthropy can have for a business. The cancer center has received several large donations in the past, such as a 2006 donation from Mr. Zuckerman, and two separate times from donors Daniel Ludwig and Henry Kravis in 2014. This new facility’s construction was undoubtedly made possible by these generous donations.
The current expectation is that the new facility will open by 2018, as that is when the Rockville Centre lease expires. You can learn more about the construction project by visiting Memorial Sloan Kettering’s website.